Persistence of balloon-induced arterial injury with hyperlipidemia despite gemfibrozil

C Lundgren1, B E Sobel, S Fujii

  • 1Division of Cardiology, Wahington University School of Medicine, St. Louis, Missouri 63110, USA.

Japanese Heart Journal
|January 1, 1996
PubMed

Insights

Gemfibrozil did not prevent restenosis in hypercholesterolemic rabbits, with increased intimal thickening observed. However, it may reduce thrombotic occlusion by affecting fibrinolysis, independent of lipid levels.

Area of Science:

  • Vascular Biology
  • Cardiovascular Research
  • Pharmacology

Background:

  • Restenosis post-angioplasty involves smooth muscle cell migration and macrophage infiltration.
  • Hypercholesterolemia may exacerbate vascular remodeling after injury.
  • Gemfibrozil is a lipid-lowering agent with potential anti-inflammatory effects.

Purpose of the Study:

  • To investigate if gemfibrozil attenuates hypercholesterolemia-induced vascular remodeling after mechanical injury.
  • To assess the impact of gemfibrozil on intimal thickening and macrophage infiltration in a rabbit model.
  • To explore gemfibrozil's effects independent of lipid metabolism.

Main Methods:

  • New Zealand white rabbits were fed control, cholesterol-enriched, or cholesterol-enriched plus gemfibrozil diets.
  • Balloon-induced carotid injury was performed, followed by 4 weeks of maintained diet.
  • Vascular histology, intimal thickening, and macrophage infiltration were analyzed.

Main Results:

  • Gemfibrozil did not alter plasma triglycerides or cholesterol levels.
  • Hypercholesterolemic rabbits showed similar intimal thickening to controls, but with higher thrombotic occlusion.
  • Gemfibrozil-treated rabbits had increased intimal thickening and macrophage infiltration compared to controls.
  • Gemfibrozil attenuated thrombotic luminal occlusion in hypercholesterolemic rabbits.

Conclusions:

  • Gemfibrozil did not attenuate vascular remodeling or intimal thickening in hypercholesterolemic rabbits.
  • Gemfibrozil's reduction of thrombotic occlusion may be linked to effects on fibrinolytic systems, not lipid metabolism.
  • Further research is needed to understand gemfibrozil's role in vascular injury response.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...